Speaker
Description
In nuclear medicine, radioisotopes are injected into a patient to perform functional imaging or targeted radionuclide therapy. However, only a handful of radioisotopes are used in this field, mostly limited by a supply-and-demand closed loop that does not leave room for innovation. At radioactive ion beam facilities, however, we can provide a wide catalogue of radioisotopes to support medical research and break that conundrum. At CERN, the MEDICIS facility (MEDical Isotopes Collected from ISolde) has been established and provides radioisotopes for medical research regularly since 2018. On the European landscape, many facilities have federated themselves as PRISMAP - The European Medical Radionuclides Programme to push this innovation even further. In this contribution, I shall present the added value of those novel radionuclides, the pathway to translational research, and the prospects brought by these new initiatives.
| Topic | Applications |
|---|
